Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrest Nicholson Regulatory News (CRST)

Share Price Information for Crest Nicholson (CRST)

Share Price is delayed by 15 minutes
Get Live Data
67.70    -1.50 (-2.17%)
Bid:
67.30
Ask:
67.80
Spread: 0.50 (0.743%)
Market Cap: £173.81m
CRST Live PriceLast checked at - London Stock Exchange

Intraday Crest Nicholson Share Chart

Trading Statement

18 Nov 2025 07:00

RNS Number : 8831H
Crest Nicholson Holdings PLC
18 November 2025
 

 Crest Nicholson Holdings plc

(the "Group" or "Crest Nicholson")

Good progress on strategic priorities

Positive progress on land sales

FY25 APBT at the low end of, or marginally below, guidance

 

Crest Nicholson today provides an update on trading for the year ending 31 October 2025.

Martyn Clark, CEO commented:

"We launched our new strategic priorities at our Capital Markets Day in March this year and have made good progress in executing our transformation plan, Project Elevate. Encouragingly, progress across a number of areas is already evident, reflecting the early benefits of actions taken. We believe these will convert to positive financial contributions as we progress further in our transformation plan.

A key focus area of our strategy is the balance sheet where we have tightened our grip on inventory and cost control. We also committed to take action to address our land bank to ensure it is right-sized and better aligned to our strategy and product offering. We are therefore pleased by the positive progress on land sales on good economic terms in the second half of the year, which, in combination with our cash focus, has seen us finish the year with net debt at the better end of the guidance range of £40-90m. These land transactions support our ongoing efforts to strengthen the balance sheet and provide greater flexibility to invest in and acquire mid-premium land opportunities. This positions us well to grow our outlets in the years ahead.

Our Adjusted Profit Before Tax performance (APBT) for FY25 is expected to be at the low end of, or marginally below the guidance range of £28-38m, reflecting a housing market that has remained subdued through the summer, and the continued uncertainty surrounding Government tax policy ahead of the forthcoming Budget.

While near-term market conditions are expected to remain challenging, our enhanced operating discipline, improved balance sheet and clear strategic direction provide a robust platform to navigate the current environment and deliver long-term, sustainable growth."

FY25 trading and financial highlights

· FY25 volume 1,691 units, at the lower end of the guidance range of 1,700-1,900 units with c.35% of affordable and PRS units reflecting lower level of PRS in FY25 in line with our strategy

· Open market sales units increased by 5% to 1,095, demonstrating enhancements to our sales strategy

· FY25 open market sales rate at 0.51 (FY24: 0.48), with the sales rate for the last 13 weeks of the financial year at 0.45

· APBT expected to be at the low end of, or marginally below, the guidance range of £28m-38m

· Anticipated opening reserves adjustment to inventory of c.£8m reflecting overstated profit in relation to one development in the Eastern division between FY22 and FY24. The impact on APBT in each of those years is not expected to be material

· Year-end net debt at the better end of the guidance range of £40m-£90m with c.£50m of land receipts secured for FY26

Strategic and operational highlights

· Successful disposals of five land parcels from larger sites, in line with our land strategy

· As part of Project Elevate, a collective consultation is underway following an announcement of the proposed closure of one divisional office and selective other roles being placed at risk of redundancy across overhead functions impacting c.50 roles

· The Group is seeing some build cost inflation in line with the sector but our self-help initiatives are under way to drive better cost performance

· Notable improvements in build quality, sales performance, and customer satisfaction scores, with external recognition from NHBC and Premier for five sites

· Secured key planning wins to reinforce our high-quality strategic land pipeline, underpinning future outlet growth and margin expansion. We are seeing encouraging improvements in the planning environment with 66% of our strategic land bank now allocated or in draft allocation stage (FY24: 50%)

· Excellent progress on our new house type range, with the design phase to be finalised by December 2025

· Strengthened customer experience through enhanced training, technology investment, and improved customer journey, aligned with the expectations of the mid-premium market

· Launched the Arteva upgrade range, offering personalisation options which has generated strong interest and early financial benefits.

 

For further information, please contact:

Crest Nicholson

Jenny Matthews, Head of Investor Relations +44 (0) 7557 842720

Teneo

James Macey White / Ollie Simmonds +44 (0) 207 260 2700

 

18 November 2025

The person responsible for arranging the release of this announcement on behalf of the Company is Penny Thomas, Group Company Secretary.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTMZMMMLNLGKZM
Date   Source Headline
29th May 202610:34 amRNSADMISSION TO TRADING AND TOTAL VOTING RIGHTS
21st May 20269:52 amRNSHolding(s) in Company
20th May 20262:28 pmRNSHolding(s) in Company
19th May 20267:00 amRNSRevised date for the half year results
12th May 20262:09 pmRNSDirector/PDMR Shareholding
1st May 20264:26 pmRNSHolding(s) in Company
30th Apr 20264:04 pmRNSADMISSION TO TRADING AND TOTAL VOTING RIGHTS
28th Apr 20262:56 pmRNSDirector/PDMR Shareholding
24th Apr 20264:47 pmRNSDirector/PDMR Shareholding
21st Apr 20267:00 amRNSTrading Update
20th Apr 20265:21 pmRNSHolding(s) in Company
10th Apr 20264:14 pmRNSDirector/PDMR Shareholding
7th Apr 20269:57 amRNSAdmission to Trading
31st Mar 20263:23 pmRNSTotal Voting Rights
26th Mar 20263:24 pmRNSDirector/PDMR Shareholding
25th Mar 202611:59 amRNSResult of AGM
25th Mar 20267:00 amRNSTrading Statement
24th Mar 20268:45 amRNSDirector/PDMR Shareholding
10th Mar 20264:40 pmRNSDirector/PDMR Shareholding
10th Mar 20264:40 pmRNSDirector/PDMR Shareholding
3rd Mar 20265:22 pmRNSDirector/PDMR Shareholding
27th Feb 20262:37 pmRNSTotal Voting Rights
17th Feb 202610:38 amRNSAnnual Report & Notice of AGM
10th Feb 20265:04 pmRNSDirector/PDMR Shareholding
30th Jan 20262:11 pmRNSTotal Voting Rights
29th Jan 20267:00 amRNSFinal Results
12th Jan 20265:02 pmRNSDirector/PDMR Shareholding
23rd Dec 20253:46 pmRNSTotal Voting Rights
23rd Dec 20253:46 pmRNSTotal Voting Rights
10th Dec 20254:07 pmRNSDirector/PDMR Shareholding
5th Dec 202510:22 amRNSDirector Declaration
28th Nov 20252:55 pmRNSTotal Voting Rights
19th Nov 202512:59 pmRNSHolding(s) in Company
18th Nov 20257:00 amRNSTrading Statement
11th Nov 202512:32 pmRNSDirector/PDMR Shareholding
5th Nov 202510:40 amRNSHolding(s) in Company
31st Oct 20255:07 pmRNSTotal Voting Rights
28th Oct 202511:06 amRNSHolding(s) in Company
28th Oct 202510:02 amRNSDirectorate Change
24th Oct 20253:05 pmRNSHolding(s) in Company
17th Oct 202510:08 amRNSBlock listing Interim Review
10th Oct 20254:21 pmRNSDirector/PDMR Shareholding
30th Sep 202512:07 pmRNSTotal Voting Rights
22nd Sep 20252:48 pmRNSHolding(s) in Company
11th Sep 20254:07 pmRNSDirector/PDMR Shareholding
3rd Sep 20253:48 pmRNSHolding(s) in Company
29th Aug 20251:28 pmRNSTotal Voting Rights
13th Aug 20259:58 amRNSDirector/PDMR Shareholding
1st Aug 20254:46 pmRNSHolding(s) in Company
31st Jul 20252:10 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.